Selected research
Industry Research
Melanocyte Protein PMEL Industry Research Report 2026
Market perspective
The global Melanocyte Protein PMEL market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Melanocyte Protein PMEL is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Melanocyte Protein PMEL is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Melanocyte Protein PMEL is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Melanocyte Protein PMEL include Vault Pharma Inc., Scancell Holdings Plc, Immunomic Therapeutics, Inc., ImmunoCellular Therapeutics, Ltd. and Antigen Express, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Melanocyte Protein PMEL market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Melanocyte Protein PMEL Market by Company
Vault Pharma Inc.
Scancell Holdings Plc
Immunomic Therapeutics, Inc.
ImmunoCellular Therapeutics, Ltd.
Antigen Express, Inc.
Melanocyte Protein PMEL Segment by Type
VPI-121
SCIB-1
AE-M vaccine
Others
Melanocyte Protein PMEL Segment by Application
Metastatic Melanoma
Melanoma
Glioblastoma Multiforme
Melanocyte Protein PMEL Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Melanocyte Protein PMEL market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Melanocyte Protein PMEL and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Melanocyte Protein PMEL.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Melanocyte Protein PMEL manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Melanocyte Protein PMEL by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Melanocyte Protein PMEL in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- VPI-121
- SCIB-1
- AE-M vaccine
- Others
Applications
- Metastatic Melanoma
- Melanoma
- Glioblastoma Multiforme
Companies covered
- Vault Pharma Inc.
- Scancell Holdings Plc
- Immunomic Therapeutics, Inc.
- ImmunoCellular Therapeutics, Ltd.
- Antigen Express, Inc.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Melanocyte Protein PMEL Market Size (2021-2032)
- 2.2.2 Global Melanocyte Protein PMEL Sales (2021-2032)
- 2.2.3 Global Melanocyte Protein PMEL Market Average Price (2021-2032)
- 2.3 Melanocyte Protein PMEL by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 VPI-121
- 2.3.3 SCIB-1
- 2.3.4 AE-M vaccine
- 2.3.5 Others
- 2.4 Melanocyte Protein PMEL by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Metastatic Melanoma
- 2.4.3 Melanoma
- 2.4.4 Glioblastoma Multiforme
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Melanocyte Protein PMEL Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Melanocyte Protein PMEL Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Melanocyte Protein PMEL Revenue of Manufacturers (2021-2026)
- 3.4 Global Melanocyte Protein PMEL Average Price by Manufacturers (2021-2026)
- 3.5 Global Melanocyte Protein PMEL Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Melanocyte Protein PMEL, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Melanocyte Protein PMEL, Product Type & Application
- 3.8 Global Manufacturers of Melanocyte Protein PMEL, Established Date
- 3.9 Global Melanocyte Protein PMEL Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Vault Pharma Inc.
- 4.1.1 Vault Pharma Inc. Company Information
- 4.1.2 Vault Pharma Inc. Business Overview
- 4.1.3 Vault Pharma Inc. Melanocyte Protein PMEL Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Vault Pharma Inc. Melanocyte Protein PMEL Product Portfolio
- 4.1.5 Vault Pharma Inc. Recent Developments
- 4.2 Scancell Holdings Plc
- 4.2.1 Scancell Holdings Plc Company Information
- 4.2.2 Scancell Holdings Plc Business Overview
- 4.2.3 Scancell Holdings Plc Melanocyte Protein PMEL Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Scancell Holdings Plc Melanocyte Protein PMEL Product Portfolio
- 4.2.5 Scancell Holdings Plc Recent Developments
- 4.3 Immunomic Therapeutics, Inc.
- 4.3.1 Immunomic Therapeutics, Inc. Company Information
- 4.3.2 Immunomic Therapeutics, Inc. Business Overview
- 4.3.3 Immunomic Therapeutics, Inc. Melanocyte Protein PMEL Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Immunomic Therapeutics, Inc. Melanocyte Protein PMEL Product Portfolio
- 4.3.5 Immunomic Therapeutics, Inc. Recent Developments
- 4.4 ImmunoCellular Therapeutics, Ltd.
- 4.4.1 ImmunoCellular Therapeutics, Ltd. Company Information
- 4.4.2 ImmunoCellular Therapeutics, Ltd. Business Overview
- 4.4.3 ImmunoCellular Therapeutics, Ltd. Melanocyte Protein PMEL Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 ImmunoCellular Therapeutics, Ltd. Melanocyte Protein PMEL Product Portfolio
- 4.4.5 ImmunoCellular Therapeutics, Ltd. Recent Developments
- 4.5 Antigen Express, Inc.
- 4.5.1 Antigen Express, Inc. Company Information
- 4.5.2 Antigen Express, Inc. Business Overview
- 4.5.3 Antigen Express, Inc. Melanocyte Protein PMEL Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Antigen Express, Inc. Melanocyte Protein PMEL Product Portfolio
- 4.5.5 Antigen Express, Inc. Recent Developments
5 Global Melanocyte Protein PMEL Market Scenario by Region
- 5.1 Global Melanocyte Protein PMEL Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Melanocyte Protein PMEL Sales by Region: 2021-2032
- 5.2.1 Global Melanocyte Protein PMEL Sales by Region: 2021-2026
- 5.2.2 Global Melanocyte Protein PMEL Sales by Region: 2027-2032
- 5.3 Global Melanocyte Protein PMEL Revenue by Region: 2021-2032
- 5.3.1 Global Melanocyte Protein PMEL Revenue by Region: 2021-2026
- 5.3.2 Global Melanocyte Protein PMEL Revenue by Region: 2027-2032
- 5.4 North America Melanocyte Protein PMEL Market Facts & Figures by Country
- 5.4.1 North America Melanocyte Protein PMEL Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Melanocyte Protein PMEL Sales by Country (2021-2032)
- 5.4.3 North America Melanocyte Protein PMEL Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Melanocyte Protein PMEL Market Facts & Figures by Country
- 5.5.1 Europe Melanocyte Protein PMEL Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Melanocyte Protein PMEL Sales by Country (2021-2032)
- 5.5.3 Europe Melanocyte Protein PMEL Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Melanocyte Protein PMEL Market Facts & Figures by Country
- 5.6.1 Asia Pacific Melanocyte Protein PMEL Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Melanocyte Protein PMEL Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Melanocyte Protein PMEL Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Melanocyte Protein PMEL Market Facts & Figures by Country
- 5.7.1 South America Melanocyte Protein PMEL Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Melanocyte Protein PMEL Sales by Country (2021-2032)
- 5.7.3 South America Melanocyte Protein PMEL Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Melanocyte Protein PMEL Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Melanocyte Protein PMEL Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Melanocyte Protein PMEL Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Melanocyte Protein PMEL Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Melanocyte Protein PMEL Sales by Type (2021-2032)
- 6.1.1 Global Melanocyte Protein PMEL Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Melanocyte Protein PMEL Sales Market Share by Type (2021-2032)
- 6.2 Global Melanocyte Protein PMEL Revenue by Type (2021-2032)
- 6.2.1 Global Melanocyte Protein PMEL Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Melanocyte Protein PMEL Revenue Market Share by Type (2021-2032)
- 6.3 Global Melanocyte Protein PMEL Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Melanocyte Protein PMEL Sales by Application (2021-2032)
- 7.1.1 Global Melanocyte Protein PMEL Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Melanocyte Protein PMEL Sales Market Share by Application (2021-2032)
- 7.2 Global Melanocyte Protein PMEL Revenue by Application (2021-2032)
- 7.2.1 Global Melanocyte Protein PMEL Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Melanocyte Protein PMEL Revenue Market Share by Application (2021-2032)
- 7.3 Global Melanocyte Protein PMEL Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Melanocyte Protein PMEL Value Chain Analysis
- 8.1.1 Melanocyte Protein PMEL Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Melanocyte Protein PMEL Production Mode & Process
- 8.2 Melanocyte Protein PMEL Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Melanocyte Protein PMEL Distributors
- 8.2.3 Melanocyte Protein PMEL Customers
9 Global Melanocyte Protein PMEL Analyzing Market Dynamics
- 9.1 Melanocyte Protein PMEL Industry Trends
- 9.2 Melanocyte Protein PMEL Industry Drivers
- 9.3 Melanocyte Protein PMEL Industry Opportunities and Challenges
- 9.4 Melanocyte Protein PMEL Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst